Guo L - Search Results

1

Comparing the differential effects of LPA on the barrier function of human pulmonary endothelial cells.

Ren Y, Guo L, Tang X, Apparsundaram S, Kitson C, Deguzman J, Fuentes ME, Coyle L, Majmudar R, Allard J, Truitt T, Hamid R, Chen Y, Qian Y, Budd DC. Ren Y, et al. Among authors: guo l. Microvasc Res. 2013 Jan;85:59-67. doi: 10.1016/j.mvr.2012.10.004. Epub 2012 Oct 16. Microvasc Res. 2013. PMID: 23084965

2

Refining the human iPSC-cardiomyocyte arrhythmic risk assessment model.

Guo L, Coyle L, Abrams RM, Kemper R, Chiao ET, Kolaja KL. Guo L, et al. Toxicol Sci. 2013 Dec;136(2):581-94. doi: 10.1093/toxsci/kft205. Epub 2013 Sep 19. Toxicol Sci. 2013. PMID: 24052561

3

The electrophysiological effects of cardiac glycosides in human iPSC-derived cardiomyocytes and in guinea pig isolated hearts.

Guo L, Qian JY, Abrams R, Tang HM, Weiser T, Sanders MJ, Kolaja KL. Guo L, et al. Cell Physiol Biochem. 2011;27(5):453-62. doi: 10.1159/000329966. Epub 2011 Jun 15. Cell Physiol Biochem. 2011. PMID: 21691062

4

Use of human stem cell derived cardiomyocytes to examine sunitinib mediated cardiotoxicity and electrophysiological alterations.

Cohen JD, Babiarz JE, Abrams RM, Guo L, Kameoka S, Chiao E, Taunton J, Kolaja KL. Cohen JD, et al. Among authors: guo l. Toxicol Appl Pharmacol. 2011 Nov 15;257(1):74-83. doi: 10.1016/j.taap.2011.08.020. Epub 2011 Aug 27. Toxicol Appl Pharmacol. 2011. PMID: 21906609 Free PMC article.

5

Altered cytosolic Ca2+ dynamics in cultured Guinea pig cardiomyocytes as an in vitro model to identify potential cardiotoxicants.

Qian JY, Guo L. Qian JY, et al. Among authors: guo l. Toxicol In Vitro. 2010 Apr;24(3):960-72. doi: 10.1016/j.tiv.2009.12.027. Epub 2010 Jan 11. Toxicol In Vitro. 2010. PMID: 20064605

6

Estimating the risk of drug-induced proarrhythmia using human induced pluripotent stem cell-derived cardiomyocytes.

Guo L, Abrams RM, Babiarz JE, Cohen JD, Kameoka S, Sanders MJ, Chiao E, Kolaja KL. Guo L, et al. Toxicol Sci. 2011 Sep;123(1):281-9. doi: 10.1093/toxsci/kfr158. Epub 2011 Jun 20. Toxicol Sci. 2011. PMID: 21693436

7

Automated electrophysiology in the preclinical evaluation of drugs for potential QT prolongation.

Guo L, Guthrie H. Guo L, et al. J Pharmacol Toxicol Methods. 2005 Jul-Aug;52(1):123-35. doi: 10.1016/j.vascn.2005.04.002. J Pharmacol Toxicol Methods. 2005. PMID: 15936217

8

Validation of a guinea pig Langendorff heart model for assessing potential cardiovascular liability of drug candidates.

Guo L, Dong Z, Guthrie H. Guo L, et al. J Pharmacol Toxicol Methods. 2009 Sep-Oct;60(2):130-51. doi: 10.1016/j.vascn.2009.07.002. Epub 2009 Jul 18. J Pharmacol Toxicol Methods. 2009. PMID: 19616638

9

Human stem cell-derived cardiomyocytes in cellular impedance assays: bringing cardiotoxicity screening to the front line.

Peters MF, Lamore SD, Guo L, Scott CW, Kolaja KL. Peters MF, et al. Among authors: guo l. Cardiovasc Toxicol. 2015 Apr;15(2):127-39. doi: 10.1007/s12012-014-9268-9. Cardiovasc Toxicol. 2015. PMID: 25134468 Review.

10

[(2-Dimesitylboryl)phenyl]ethynyl-Substituted [2.2]Paracyclophane Exhibiting Circularly Polarized Luminescence in Both Solution and Solid-State.

Guo L, Zhang M, Zhao C. Guo L, et al. Molecules. 2025 Jan 18;30(2):390. doi: 10.3390/molecules30020390. Molecules. 2025. PMID: 39860259

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21,870 results

Search Page

Filters